Affiliation:
1. Anna Nery School of Nursing Federal University of Rio de Janeiro Rio de Janeiro Brazil
2. José Alencar Gomes da Silva National Cancer Institute Rio de Janeiro Brazil
3. Aurora of Afonso Costa School of Nursing Federal Fluminense University Rio de Janeiro Brazil
Abstract
AbstractThe evidence on products for the prevention of radiodermatitis is limited. The primary objective was to analyse the effectiveness of the spray skin protectant ‘non‐burning barrier film’ in the prevention of radiodermatitis with moist desquamation in patients with the anal canal and rectal cancer followed in nursing consultations compared to a standardised moisturiser based on Calendula officinalis and Aloe barbadensis. Single‐blind randomised clinical trial. The study was performed in a hospital in Rio de Janeiro, Brazil, with 63 patients undergoing anal canal and rectal cancer treatment, randomised into one of the following two groups: an experimental group, which used a spray skin protectant and a control group, which used a moisturiser. Data were collected using an initial and subsequent evaluation form and were assessed using descriptive and inferential analyses. Participants who used the spray skin protectant had a lower chance of presenting radiodermatitis with moist desquamation and a longer time without this outcome when compared to the control group. The overall incidence of radiodermatitis was 100%, with 36.5% being severe. Furthermore, 17.5% of participants discontinued radiotherapy due to radiodermatitis. There were no differences between the groups regarding the severity of radiodermatitis and the number of patients who discontinued radiotherapy. The skin protectant was effective in preventing radiodermatitis with moist desquamation amongst patients with anal canal and rectal cancer.
Funder
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
Reference40 articles.
1. Radiation dermatitis: recognition, prevention, and management;Leventhal J;Oncology (Williston Park),2017
2. US Department of Health and Human Services.Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. 2017. Available from:https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcae_v5_quick_reference_8.5x11.pdf. Accessed April 9 2023
3. Update on the management of the gastrointestinal effects of radiation